Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-(2-{2-(2-{4-Benzothiazol-2- y1-phenoxy}-ethoxy]-ethoxy}-ethoxy}-ethanol |
---|---|
Date Designated: | 05/24/2021 |
Orphan Designation: | Treatment of Amyotrophic Lateral Sclerosis (ALS) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Spinogenix, Inc 10210 Campus Point Drive, Suite 150 San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-